Literature DB >> 6571706

Comparison of dye exclusion assays with a clonogenic assay in the determination of drug-induced cytotoxicity.

L M Weisenthal, P L Dill, N B Kurnick, M E Lippman.   

Abstract

The following factors must be considered when dye exclusion assays are interpreted. (a) It may require several days for lethally damaged cells to lose their membrane integrity following a cytotoxic insult. (b) During this time, the "surviving" cells may continue to proliferate. (c) Also during this time, some lethally damaged cells may undergo an early disintegration, so that they are not present to be stained with dye at the end of the culture period. Factors b and c may cause an underestimate of cell kill when the results of the assay are based upon the traditional "percent viability" expression. In order to overcome these problems, an internal standard was developed and tested. This was based upon the addition of a constant number of permanently fixed duck erythrocytes to the cultures of cells from two different established tumor cell lines. Results were based upon comparisons of the ratios of "viable" tumor cells to duck erythrocytes on permanent cytocentrifuge slides prepared from the cultures. This novel "ratio" method was found to be a more sensitive index of drug-induced cell kill than the traditional percent viability method. A standard agar cloning assay gave somewhat higher estimates of cell kill than the ratio method, although both assays were in qualitative agreement for the drugs tested. All three assays demonstrated a clear dose-effect relationship for most of the drugs tested. Dye exclusion assays may have a useful role in chemosensitivity testing in vitro.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6571706

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  28 in total

1.  Chemosensitivity study of urological malignancies using a novel dye-exclusion method.

Authors:  K Naito; H Hisazumi; S Mihara; T Asari; K Kobashi; T Amano; T Uchibayashi
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

2.  Intracellular concentrations of anti cancer drugs in leukemic cells in vitro vs in vivo.

Authors:  B Sundman-Engberg; U Tidefelt; J Liliemark; C Paul
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  Static image analysis as new approach for the characterization of tumor cell lysate used in dendritic cell vaccine preparation.

Authors:  Isabelle Müller; Dorothee Hartmann; Joachim Oertel; Cornelia M Keck; Hermann Eichler
Journal:  Transfus Med Hemother       Date:  2015-01-29       Impact factor: 3.747

Review 4.  Perspectives in chemosensitivity and chemoresistance assays and their implementation in head and neck cancer.

Authors:  Lara Bussmann; Chia-Jung Busch; Balazs B Lörincz; Thorsten Rieckmann; Andreas Block; Rainald Knecht
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-01-11       Impact factor: 2.503

Review 5.  Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. II. Assay methods, adriamycin and the other antitumour antibiotics.

Authors:  A G Bosanquet
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 6.  Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. III. Antimetabolites, tubulin-binding agents, platinum drugs, amsacrine, L-asparaginase, interferons, steroids and other miscellaneous antitumor agents.

Authors:  A G Bosanquet
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

7.  Cell dissociation techniques in human breast cancer--variations in tumor cell viability and DNA ploidy.

Authors:  B M Ljung; B Mayall; C Lottich; C Boyer; S S Sylvester; G S Leight; H F Siegler; H S Smith
Journal:  Breast Cancer Res Treat       Date:  1989-03       Impact factor: 4.872

Review 8.  In vitro assays for the evaluation of drug resistance in tumor cells.

Authors:  Jozef Hatok; Eva Babusikova; Tatiana Matakova; Dusan Mistuna; Dusan Dobrota; Peter Racay
Journal:  Clin Exp Med       Date:  2008-09-26       Impact factor: 3.984

9.  Test for chemotherapeutic sensitivity of cerebral gliomas: use of colorimetric MTT assay.

Authors:  J P Jordan; C M Hand; R S Markowitz; P Black
Journal:  J Neurooncol       Date:  1992-09       Impact factor: 4.130

Review 10.  Prediction of response to drug therapy of cancer. A review of in vitro assays.

Authors:  W T Bellamy
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.